Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001824293-24-000088
Filing Date
2024-07-23
Accepted
2024-07-23 16:09:07
Documents
4
Period of Report
2024-08-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2024proxystatement.htm PRE 14A 664677
2 GRAPHIC image_0a.jpg GRAPHIC 24263
3 GRAPHIC pcpg1a.jpg GRAPHIC 126698
4 GRAPHIC pcpg2a.jpg GRAPHIC 113285
  Complete submission text file 0001824293-24-000088.txt   1030165
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40034 | Film No.: 241134543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)